atenolol has been researched along with Bernard Syndrome in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murphy, I | 1 |
| Moneley, D | 1 |
| Kelly, D | 1 |
| Foley, B | 1 |
| Sheehan, S | 1 |
1 other study available for atenolol and Bernard Syndrome
| Article | Year |
|---|---|
Endoscopic thoracic sympathectomy for long QT syndrome.
Topics: Adrenergic beta-Antagonists; Atenolol; Defibrillators, Implantable; Electric Countershock; Female; H | 2008 |